| Target Price | $346.80 |
| Price | $271.83 |
| Potential |
27.58%
register free of charge
|
| Number of Estimates | 29 |
|
29 Analysts have issued a price target Cigna 2027 .
The average Cigna target price is $346.80.
This is
27.58%
register free of charge
$420.00
54.51%
register free of charge
$292.90
7.75%
register free of charge
|
|
| A rating was issued by 34 analysts: 26 Analysts recommend Cigna to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cigna stock has an average upside potential 2027 of
27.58%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 274.90 | 296.16 |
| 11.24% | 7.73% | |
| EBITDA Margin | 4.37% | 4.64% |
| 5.32% | 6.28% | |
| Net Margin | 2.17% | 2.80% |
| 55.94% | 29.21% |
29 Analysts have issued a sales forecast Cigna 2026 . The average Cigna sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Cigna EBITDA forecast 2026. The average Cigna EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
30 Cigna Analysts have issued a net profit forecast 2026. The average Cigna net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 22.18 | 31.41 |
| 83.00% | 41.61% | |
| P/E | 8.65 | |
| EV/Sales | 0.33 |
30 Analysts have issued a Cigna forecast for earnings per share. The average Cigna EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Jefferies |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| Raymond James |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Barclays |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Bernstein |
Locked
➜
Locked
|
Locked | Jul 09 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jun 08 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Jefferies:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
Raymond James:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Barclays:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
Bernstein:
Locked
➜
Locked
|
Jul 09 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jun 08 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


